What thyssenkrupp nucera KGaA Bears Saw Before The Fall

Fresh headlines have been kind to the green hydrogen story, with Custom Market Insights flagging thyssenkrupp nucera KGaA as an active player in a market that one research house now expects to reach hundreds of billions of dollars. For thyssenkrupp nucera KGaA shareholders, the loss over the past year was 26.0%, including dividends. If you had bought before those upbeat forecasts and the BHEL electrolyser deal in India, what did that gap between sector optimism and your result really rest on?

On Simply Wall St, a Narrative is an investor's thesis written down: the reasoning, plus the numbers it rests on. Run those numbers and you get an estimated Fair Value.

thyssenkrupp nucera KGaA has already moved. See which of 188 high quality undervalued stocks still trade below our estimates.

The Argument You Would Have Been Weighing On thyssenkrupp nucera KGaA

At the start, the shares cost €10.54. Any thesis on thyssenkrupp nucera KGaA had to choose between two very different but credible stories.

The bullish narrative put fair value at €11.61, framed around green hydrogen demand supported by global decarbonization policies and paid engineering work that might convert into larger orders.

The bearish view pointed to a fair value of €8.70, stressing delays and cancellations in large-scale projects that could depress the project pipeline and make revenue more volatile.

What The Results Changed For thyssenkrupp nucera KGaA

The electrolyser partnership with BHEL in India backed the bullish idea that thyssenkrupp nucera KGaA could win meaningful roles in green hydrogen build outs. Quarterly figures told a cooler story. Revenue went from €184 million in Q3 2025 to €145 million in Q3 2026, while a loss of €2 million shifted to roughly break even. The evidence pointed in both directions.

The whole episode turned on whether project wins translated into healthier profitability. For another stock built on big contracts, it can be useful to track order intake alongside revenue and net margin, then test the story whenever profits improve while sales soften.

What Today's €8.32 Price Asks You To Believe About thyssenkrupp nucera KGaA

With thyssenkrupp nucera KGaA now trading at €8.32 and down 26.0% over the past year, the selected Narrative still places its Fair Value above that level based on long-dated hydrogen work and higher-margin service activity.

For this fall to look like an opening rather than a warning, a buyer would need to believe deferred green hydrogen projects convert into sizeable, profitable orders as paid engineering work and policy support feed through.

"Recent project delays and smaller average project size have weighed on near-term revenues, but thyssenkrupp nucera sits at the center of a major long-term shift as global decarbonization policies and corporate net-zero mandates support the structural ramp-up in green hydrogen demand, likely driving a reacceleration in order intake and revenue growth as regulatory certainty and infrastructure buildout progresses."

Not everyone reads the same price the same way. → See the higher figure this Narrative lands on, and how it gets there

Before The Next Story Makes Headlines

This company's disappointment is already part of the story. Your next idea could come from looking where the price and the possibilities still seem far apart. Here are three companies priced below our estimates.

• Company 1 - 49% below our estimate - sells higher margin retrofit and digital upgrades as dual fuel engines spread through fleets.
• Company 2 - 38% below our estimate - uses AI matching tools to deepen monetization of hiring, staffing and local services platforms.
• Company 3 - 47% below our estimate - gains betting and casino users as offline gamblers switch to its digital platform and apps.

Three companies from the same screener. Open every one of the 203 solid balance sheet companies →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com